Advanced precancerous lesions within the GI tract: the molecular background.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Best practice & research. Clinical gastroenterology

• Publication date

  2013-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bpg.2013.03.009PMID 23809238
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• microRNA involvement in human cancer.

  2025cited by this paper
• Advanced precancerous lesions in the liver.

  2013cited by this paper
• Esophageal squamous cell carcinoma with special reference to its early stage.

  2013cited by this paper
• Advanced precancerous lesions in the small bowel mucosa.

  2013cited by this paper
• Advanced precancerous lesions (APL) in the colonic mucosa.

  2013cited by this paper
• Precancerous lesions in inflammatory bowel disease.

  2013cited by this paper
• Precancerous lesions of the biliary tree.

  2013cited by this paper
• Dysplasia in inflammatory bowel diseases.

  2013cited by this paper
• Precancerous lesions in the stomach: from biology to clinical patient management.

  2013cited by this paper
• Precancerous lesions of the pancreas.

  2013cited by this paper
• Advanced precancerous lesions in the lower oesophageal mucosa: high-grade dysplasia and intramucosal carcinoma in Barrett's oesophagus.

  2013cited by this paper
• microRNA involvement in human cancer.

  2012cited by this paper
• Early HER2 dysregulation in gastric and oesophageal carcinogenesis

  2012cited by this paper
• The adenoma hunt in colorectal cancer screening: defining the target

  2012cited by this paper
• MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy.

  2012cited by this paper
• Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis.

  2012cited by this paper
• microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6

  2012cited by this paper
• Clinical guidelines: Secondary prevention of gastric cancer

  2012cited by this paper
• Risk Factors for Gallbladder Cancer and Cholangiocarcinoma: Similarities, Differences and Updates

  2012cited by this paper
• Causes and Consequences of MicroRNA Dysregulation

  2012cited by this paper
• Re: Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.

  2012cited by this paper
• MicroRNA Dysregulation in Esophageal Neoplasia: The Biological Rationale for Novel Therapeutic Options

  2012cited by this paper
• Liver precancerous lesions and hepatocellular carcinoma: the histology report.

  2011cited by this paper
• Microscopic esophagitis and Barrett's esophagus: the histology report.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis

  2011cited by this paper
• Long-Term Follow-up of Barrett’s Epithelium: Medical Versus Antireflux Surgical Therapy

  2011cited by this paper
• Chronic idiopathic inflammatory bowel diseases: the histology report.

  2011cited by this paper
• Update on precursor and early lesions of hepatocellular carcinomas.

  2011cited by this paper
• Gastritis: the histology report.

  2011cited by this paper
• MicroRNA expression profiling in human Barrett's carcinogenesis

  2011cited by this paper
• Using loss of heterozygosity of microsatellites to distinguish high-grade dysplastic nodule from early minute hepatocellular carcinoma.

  2011cited by this paper
• Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis.

  2011cited by this paper
• Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.

  2011cited by this paper
• Hybrid capture and next-generation sequencing identify viral integration sites from formalin-fixed, paraffin-embedded tissue.

  2011cited by this paper
• miRNAs in precancerous lesions of the gastrointestinal tract.

  2011cited by this paper
• Genetics of Hepatobiliary Carcinogenesis

  2011cited by this paper
• Carcinoma of the exocrine pancreas: the histology report.

  2011cited by this paper
• Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis

  2010cited by this paper
• Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens

  2010cited by this paper
• Molecular Signature of Early Hepatocellular Carcinoma

  2010cited by this paper
• Malignant Transformation of Non-Neoplastic Barrett's Epithelial Cells through Well-Defined Genetic Manipulations

  2010cited by this paper
• TOPOIIα and HER-2/neu overexpression/amplification in Barrett’s oesophagus, dysplasia and adenocarcinoma

  2010cited by this paper
• Aurora kinase A in Barrett's carcinogenesis.

  2010cited by this paper
• Gastritis OLGA‐staging and gastric cancer risk: a twelve‐year clinico‐pathological follow‐up study

  2010cited by this paper
• Serrated polyps of the colon and rectum (hyperplastic polyps, sessile serrated adenomas, traditional serrated adenomas, and mixed polyps)—proposal for diagnostic criteria

  2010cited by this paper
• Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis.

  2010cited by this paper
• An update on cholangiocarcinoma associated with primary sclerosing cholangitis

  2010cited by this paper
• Impact of hepatitis virus and aging on DNA methylation in human hepatocarcinogenesis.

  2010cited by this paper
• Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression

  2010cited by this paper
• Endoscopic Variceal Band Ligation

  2009cited by this paper
• Molecular classification of neoplasms of the pancreas.

  2009cited by this paper
• DNA Promoter Hypermethylation of p16 and APC Predicts Neoplastic Progression in Barrett's Esophagus

  2009cited by this paper
• MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

  2009cited by this paper
• Large liver cell change in hepatitis B virus–related liver cirrhosis

  2009cited by this paper
• Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia.

  2009cited by this paper
• Chromosomal instability, telomere shortening, and inactivation of p21WAF1/CIP1 in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis

  2009cited by this paper
• Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.

  2009cited by this paper
• A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus.

  2009cited by this paper
• Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?

  2009cited by this paper
• OLGA staging for gastritis: a tutorial.

  2008cited by this paper
• Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis

  2008cited by this paper
• Promoter Methylation in Cytology Specimens as an Early Detection Marker for Esophageal Squamous Dysplasia and Early Esophageal Squamous Cell Carcinoma

  2008cited by this paper
• HER-2 overexpression/amplification in Barrett’s oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study

  2008cited by this paper
• Micronuclei and broken eggs in human liver carcinogenesis.

  2008cited by this paper
• α‐Methylacyl‐CoA racemase (AMACR) immunohistochemistry in Barrett’s and colorectal mucosa: only significant overexpression favours a diagnosis of intraepithelial neoplasia

  2008cited by this paper
• p16, Cyclin D1, Ki-67, and AMACR as Markers for Dysplasia in Barrett Esophagus

  2008cited by this paper
• Immunohistochemical expression of cell‐cycle proteins in gastric precancerous lesions

  2008cited by this paper
• The Expression of Transforming Growth Factor-α in Cirrhosis, Dysplastic Nodules, and Hepatocellular Carcinoma: An Immunohistochemical Study of 70 Cases

  2007cited by this paper
• Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype

  2007cited by this paper
• Classification of colorectal cancer based on correlation of clinical, morphological and molecular features

  2007cited by this paper
• Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.

  2007cited by this paper
• Pathology Databanking and Biobanking in The Netherlands, a Central Role for PALGA, the Nationwide Histopathology and Cytopathology Data Network and Archive

  2007cited by this paper
• The Veneto Region's Barrett's Oesophagus Registry: aims, methods, preliminary results.

  2007cited by this paper
• Pathology of dysplasia and cancer in inflammatory bowel disease.

  2006cited by this paper
• Variability in the diagnosis of dysplasia in ulcerative colitis by dynamic telepathology.

  2006cited by this paper
• Low-grade dysplasia in Barrett's esophagus.

  2006cited by this paper
• p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions.

  2006cited by this paper
• A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

  2006cited by this paper
• Large liver cell dysplasia: a controversial entity.

  2006cited by this paper
• Diagnosis and grading of dysplasia in Barrett’s oesophagus

  2006cited by this paper
• High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy.

  2006cited by this paper
• Microsatellite instability and gastric non-invasive neoplasia in a high risk population in Cesena, Italy

  2005cited by this paper
• Differences in biological features of gastric dysplasia, indefinite dysplasia, reactive hyperplasia and discriminant analysis of these lesions.

  2005cited by this paper
• Amplification and overexpression of c‐erbB‐2, epidermal growth factor receptor, and c‐met in biliary tract cancers

  2005cited by this paper
• Clinical significance of microsatellite instability in the inflamed mucosa for the prediction of colonic neoplasms in patients with ulcerative colitis

  2005cited by this paper
• Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays

  2004cited by this paper
• Different Genetic Features Associated with Colon and Rectal Carcinogenesis

  2004cited by this paper
• An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms

  2004cited by this paper
• Carcinogenetic process in gallbladder mucosa with pancreaticobiliary maljunction (Review).

  2003cited by this paper
• Molecular pathogenesis of human hepatocellular carcinoma

  2002cited by this paper
• Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer

  2002cited by this paper
• Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers.

  2002cited by this paper
• Genetic pathways in the evolution of morphologically distinct colorectal neoplasms.

  2001cited by this paper
• Mutations in the APC tumour suppressor gene cause chromosomal instability

  2001cited by this paper
• Accelerated age-related CpG island methylation in ulcerative colitis.

  2001cited by this paper
• The Immunohistochemical Mucin Expression Pattern Distinguishes Different Types of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Determines Their Relationship to Mucinous Noncystic Carcinoma and Ductal Adenocarcinoma

  2001cited by this paper
• Dpc4 Protein in Mucinous Cystic Neoplasms of the Pancreas: Frequent Loss of Expression in Invasive Carcinomas Suggests a Role in Genetic Progression

  2000cited by this paper

• Nucleosome assembly protein 1-like 1 (NAP1L1) in gastric cancer patients: a potential biomarker with diagnostic and prognostic utility

  2024cites this paper
• Application of next-generation sequencing in the diagnosis of gastric cancer

  2022cites this paper
• Abstract. Long non‐coding (lnc) RNAs in circulating exosomes are a new class of promising cancer biomarkers; however, their expression in exosomes derived from gastric high‐grade intraepithelial neoplasia

  2021cites this paper
• The histomorphological and molecular landscape of colorectal adenomas and serrated lesions

  2021cites this paper
• Long non-coding RNA profiles in plasma exosomes of patients with gastric high-grade intraepithelial neoplasia

  2021cites this paper
• Molecular Analysis of the Involvements of lncRNA in Cancer Development

  2021cites this paper
• Biomarkers for early detection of colitis-associated colorectal cancer - current concepts, future trends.

  2020cites this paper
• Human papillomavirus infection is not involved in esophageal verrucous carcinoma.

  2019cites this paper
• Prognostic implications of MYBL2 in resected Chinese gastric adenocarcinoma patients

  2019cites this paper
• Prognostic implications of MYBl2 in resected chinese gastric adenocarcinoma patients

  2019cites this paper
• The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples

  2019cites this paper
• The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples

  2019cites this paper
• Identification of plasma RGS18 and PPBP mRNAs as potential biomarkers for gastric cancer using transcriptome arrays

  2018cites this paper
• Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers

  2018cites this paper
• Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases

  2018cites this paper
• miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis

  2018cites this paper
• The molecular landscape of colitis-associated carcinogenesis.

  2017cites this paper
• Fhit down-regulation is an early event in pancreatic carcinogenesis

  2017cites this paper
• Immunotherapy in Gastrointestinal Cancers

  2017cites this paper
• Team work and cytopathology molecular diagnosis of solid pancreatic lesions

  2017cites this paper
• Early miR-223 Upregulation in Gastroesophageal Carcinogenesis

  2017cites this paper
• Noncoding RNAs as drivers of the phenotypic plasticity of oesophageal mucosa

  2017cites this paper
• Endoscopic Ultrasonography with Fine-needle Aspiration: New Techniques for Interpretation of Endoscopic Ultrasonography Cytology and Histology Specimens.

  2017cites this paper
• Gastric Cancer as Preventable Disease

  2017cites this paper
• Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett’s carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy

  2016cites this paper
• From Barrett metaplasia to esophageal adenocarcinoma: the molecular background.

  2016cites this paper
• Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis

  2016cites this paper
• Epidemiology of Gastric Cancer

  2015cites this paper
• The stomach in health and disease

  2015cites this paper
• MicroRNAs as tools and effectors for patient treatment in gastrointestinal carcinogenesis.

  2015influential citation
• Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis

  2015cites this paper
• Liver Cancer Classification

  2015cites this paper
• Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups

  2014influential citation
• The novel long noncoding RNA AC138128.1 may be a predictive biomarker in gastric cancer

  2014cites this paper
• Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: where are we now in the era of the next generation proteomics?

  2014cites this paper
• Individual risk stratification of gastric cancer: evolving concepts and their impact on clinical practice.

  2014cites this paper
• Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer

  2014cites this paper
• Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis

  2014cites this paper
• SOX2 and CDX2 in gastric intestinal metaplasia and dysplasia: impact on differentiation

  2014cites this paper
• Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis

  2014cites this paper
• Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression

  2014cites this paper
• Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances

  2014cites this paper
• High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers

  2013influential citation